HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia

Annals of Hematology

Volumn 94, Issue 9, 2015, Pages 1477-1483

  Tian, Chen ^a   Yu, Yong ^a   Jia, Yongsheng ^a   Zhu, Lei ^a   Zhang, Yizhuo ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

AML; Apoptosis; HES1; p21; Proliferation

Indexed keywords

PROTEIN P21; TRANSCRIPTION FACTOR HES 1; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HES1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; NOTCH RECEPTOR; TUMOR SUPPRESSOR PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MONONUCLEAR CELL; CELL CYCLE ARREST; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROVIRIDAE; TUMOR XENOGRAFT; ANIMAL; BIOSYNTHESIS; CANCER TRANSPLANTATION; GENE EXPRESSION REGULATION; GENETICS; HL 60 CELL LINE; METABOLISM; MIDDLE AGED; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; U937 CELL LINE; XENOGRAFT;

ADOLESCENT; ADULT; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHILD; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HETEROGRAFTS; HL-60 CELLS; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; RECEPTORS, NOTCH; TUMOR SUPPRESSOR PROTEINS; U937 CELLS;

EID: 84938742979     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-015-2413-0     Document Type: Article

References (22)

1. Aster JC, Pear WS, Blacklow SC (2008) Notch signaling in leukemia. Annu Rev Pathol 3:587–613
2. Xu X, Zhao Y, Xu M, Dai Q, Meng W, Yang J et al (2011) Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia. Med Oncol 28:S483–S489
3. Chadwick N, Nostro MC, Baron M, Mottram R, Brady G, Buckle AM (2007) Notch signaling induces apoptosis in primary human CD34+ hematopoietic progenitor cells. Stem Cells 25:203–210
4. Lobry C, Oh P, Aifantis I (2011) Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think. J Exp Med 208(10):1931–1935
5. Li GH, Fan YZ, Liu XW, Zhang BF, Yin DD, He F et al (2010) Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein. Mol Cell Biochem 340(1–2):7–14
6. Lobry C, Ntziachristos P, Ndiaye-Lobry D, Oh P, Cimmino L, Zhu N et al (2013) Notch pathway activation targets AML initiating cell homeostasis and differentiation. J Exp Med 210(2):301–319
7. Kannan S, Sutphin RM, Hall MG, Golfman LS, Fang W, Nolo RM et al (2013) Notch activation inhibits AML growth and survival: a potential therapeutic approach. J Exp Med 210(2):321–337
8. Nakahara F, Sakata-Yanagimoto M, Komeno Y, Kato N, Uchida T, Haraguchi K et al (2010) HES1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. Blood 115(14):2872–2881
9. Tian C, Zheng G, Cao Z, Li Q, Ju Z, Wang J et al (2013) HES1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment. Cell Cycle 12(2):322–331
10. Kato T, Sakata-Yanagimoto M, Nishikii H, Ueno M, Miyake Y, Yokoyama Y et al (2015) HES1 suppresses acute myeloid leukemia development through FLT3 repression. Leukemia 29(3):576–585
11. Hughes DP (2010) How the Notch pathway contributes to the ability of osteosarcoma cells to metastasize. Cancer Treat Res 152:479–496
12. Kanamori E, Itoh M, Tojo N, Koyama T, Nara N, Tohda S (2012) Flow cytometric analysis of Notch1 and Jagged1 expression in normal blood cells and leukemia cells. Exp Ther Med 4(3):397–400
13. Mirandola L, Apicella L, Colombo M, Yu Y, Berta DG, Platonova N et al (2013) Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1. Leukemia 27(7):1558–1566
14. Tohda S, Nara N (2001) Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells. Leuk Lymphoma 42:467–472
15. Tohda S, Kogoshi H, Murakami N, Sakano S, Nara N (2005) Diverse effects of the Notch ligands Jagged1 and Delta1 on the growth and differentiation of primary acute myeloblastic leukemia cells. Exp Hematol 33(5):558–563
16. Yin G, Hou R, Li J, Zhang J, Li X, Zhang K (2012) Expression of Notch receptor and its target gene HES1 in bone marrow CD34+ cells from patients with psoriasis. Dermatology 225(2):147–153
17. Vo TT, Ryan J, Carrasco R, Neuberg D, Rossi DJ, Stone RM et al (2012) Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell 151:344–355
18. Del Giudice I, Rossi D, Chiaretti S, Marinelli M, Tavolaro S, Gabrielli S et al (2011) NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica 97:437–441
19. Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, Buonamici S et al (2011) A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature 473:230–233
20. Yu X, Alder JK, Chun JH, Friedman AD, Heimfeld S, Cheng L et al (2006) HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Stem Cells 24(4):876–888
21. Nwabo Kamdje AH, Mosna F, Bifari F, Lisi V, Bassi G, Malpeli G et al (2011) Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells. Blood 118(2):380–389
22. Dahlberg A, Delaney C, Bernstein ID (2011) Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 117:6083–6090